Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Stress Disorders, Post-Traumatic

In brief

The purpose of this research of 400 participants is to determine whether a drug called risperidone can decrease symptoms of Post-Traumatic Stress Disorder (PTSD). It is a placebo-controlled study, meaning that half of the participants will be assigned to receive a pill that contains no drug. The treatment phase of the study will last for 6 months, during which time participants will continue to receive all their usual treatments in addition to the study treatment and will be asked to complete procedures and assessments (questionnaires, interviews, laboratory tests, physical exams, etc.) related to their PTSD symptoms at various points within the 6-month treatment phase. At the end of the 6-month study, participants will discontinue the study treatment.

Key facts

Study ID
NCT00099983
Run by
US Department of Veterans Affairs
People needed
296
Starts
2006-10-01
Expected to finish
2011-01-01
Last updated by the study team
2014-08-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.